Long-term survival after post-transplant lymphoproliferative disease in children

Pediatric Nephrology

Volumn 17, Issue 8, 2002, Pages 668-672

  Nathanson, Sylvie ^a   Debray, Dominigue ^b   Delarue, Arnaud ^c   Deschênes, Georges ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Epstein Barr virus; Post transplant lymphoproliferative disease; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VINCRISTINE;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CHILD; CONTROLLED STUDY; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; T LYMPHOCYTE;

ADOLESCENT; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; PREDNISONE; SURVIVAL ANALYSIS;

EID: 0036956593     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-002-0880-8     Document Type: Article

References (22)

1. Harmon WE, Dharnidharka VR (1999) Lymphoproliferative disease in children. Transplant Proc 31:1268-1269
2. Srivastava T, Zwick DL, Rothberg PG, Warady BA (1999) Posttransplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol 13:748-754
3. Leblond V, Sutton L, Dorent R, Davi F, Bitker MO, Gabarre J, Charlotte F, Ghoussoub JJ, Fourcade C, Fischer A, Gandjbakhch I, Binet JL, Raphael M (1995) Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 13:961-968
4. Van Gorp J, Doornewaard H, Verdonck LF, Klopping C, Vos PF, Van den Tweel JG (1994) Posttransplant T-cell lymphoma. Report of three cases and a review of the literature. Cancer 73:3064-3072
5. Shiong YS, Lian JD, Lin CY, Shu KH, Chou G (1992) Epstein-Barr virus-associated T-cell lymphoma of the maxillary sinus in a renal transplant recipient. Transplant Proc 24:1929-1931
6. Rogers BB, Sommerauer J, Quan A, Timmons CF, Dawson DB, Scheuermann RH, Krisher K, Atkins C (1998) Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: three-year experience. Pediatr Dev Pathol 1:480-486
7. Dotti G, Fiocchi R, Motta T, Gamba A, Gotti E, Gridelli B, Borleri G, Manzoni C, Viero P, Remuzzi G, Barbui T, Rambaldi A (2000) Epstein-Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney, and liver transplant. Transplantation 69:827-833
8. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, Lennette ET, Martinez OM, Krams SM, Berquist WE, So SK, Esquivel CO (1995) An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK 506 after liver transplantation. Transplantation 59:524-529
9. Ho M (1995) Risk factors and pathogenesis of posttransplant lymphoproliferative disorders. Transplant Proc 27 [Suppl 11:38-40
10. Legendre C, Kreis H (1992) Effect of immunosuppression on the incidence of lymphoma formation. Clin Transplant 6:220-222
11. Calne RY, Rolles K, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Henderson RG, Aziz S, Lewis P (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreas, and 2 livers. Lancet II:1033-1036
12. Swinnen LJ (2000) Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 11 [Suppl 1]: S45-S48
13. Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME (2000) The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation 15:94-99
14. Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, Fung J, Reyes J (2000) Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 70:617-625
15. Dharnidharka VR, Sullivan EK, Stablein DM, Tejani AH, Harmon V, North American Pediatric Renal Transplant Cooperative Study (2001) Risk factors for posttransplant lymphoproliferative disorders (PTLD) in pediatric kidney transplantation: a report of the American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71:1065-1068
16. Birkeland SA, Bendtzen K, Moller B, Hamilton-Dutoit S, Andersen HK (1999) Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation. Transplantation 67:876-881
17. Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain A, Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE (1999) Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 68:1851-1854
18. Smets F, Vajro P, Cornu G, Reding R, Otte JB, Sokal E (2000) Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation. Transplantation 69:982-984
19. Caillard S, Lachat V, Moulin B, PTLD French Working Group (2000) Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. Transpl Int 13 [Suppl 1]:S388-S393
20. Grillo-Lopez AJ, White CA, Varns C, Shen D, Wei A, McClure A, Dallaire BK (1999) Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol 26 [Suppl 14]:66-73
21. Durandy A (2001) Anti-B cell and anti-cytokine therapy for the treatment of post-transplant lymphoproliferative disorder: past, present, and future. Transpl Infect Dis 3:104-107
22. Demircin G, Rees L (1997) Retransplantation after post-transplant lymphoproliferative disease. Pediatr Nephrol 11:358-360